EWSR1 and Ewing sarcoma: Hill et al. reported that nuclear immunoreactivity with C-WT1 antibody, which was observed in this case and is considered attributable to EWSR1-WT1 gene fusion, is useful for differentiating DSRCT from other small blue cell tumors, such as Ewing sarcoma [9].